Review of the first year in operation: Biotechs flock to EMEAs SME office
Biotechs flock to EMEA’s SME officeEurope’s small biotechs have leapt to take advantage of the European Medicines Agency’s (EMEA) office for SMEs, according to a review of its first year in operation.
EMEAs SME office background:
Report from the SME Office on its first year of operation
10 January 2023
Workshop #3: Reducing Pharmaceutical Residuals in the Baltic Sea Region – Comparative Analysis and Assessment of Possibilities | 9 February at 11:00-15:05 EET
4 January 2023
EDAH - a new European project ahead